Login or register (free and only takes a few minutes) to participate in this question.
You will also have access to many other tools and opportunities designed for those who have language-related jobs (or are passionate about them). Participation is free and the site has a strict confidentiality policy.
Explanation: Product Approval Information - Licensing Action
Proper name: Abciximab
Manufacturer: Centocor B.V., Leiden, The Netherlands, License #1178
Indication for Use: Extension of clinical benefits through three years and additional clinical pharmacology data.
Approval Date: 2/18/98
Type of submission: Biologics license supplement http://www.fda.gov/cber/products/abcicen021898.htm